Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PABPC1 | P11940 | 1/20 | 0.33 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.30 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10374015 | 0.78 | CA2 (0.35) | TMEM97SIGMAR1 | |
| SCHEMBL9430245 | 0.73 | PABPC1 (0.36) | PABPC1CTDSP1GAATMEM97SIGMAR1 | |
| SCHEMBL605247 | 0.72 | PABPC1 (0.41) | PABPC1CTDSP1GAATMEM97SIGMAR1 | |
| SCHEMBL8864241 | 0.71 | — | — | |
| SCHEMBL14932765 | 0.69 | PABPC1 (0.36) | PABPC1CTDSP1GAATMEM97SIGMAR1 | |
| SCHEMBL29392716 | 0.69 | PABPC1 (0.36) | PABPC1CTDSP1GAAHTR1AADRA1D | |
| SCHEMBL9159381 | 0.68 | PABPC1 (0.38) | PABPC1CTDSP1GAATMEM97SIGMAR1 | |
| SCHEMBL9107126 | 0.68 | TSHR (0.32) | TMEM97SIGMAR1 | |
| SCHEMBL9162408 | 0.68 | PABPC1 (0.38) | PABPC1CTDSP1GAATMEM97SIGMAR1 | |
| SCHEMBL28981959 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0365820-B1 | Utilization of optically active ester of oxygen containing heterocyclic carboxylic acids as doping agents in liquid crystalline mixtures, and those mixtures containing them | HOECHST AG (DE) | 1993-12-29 | — | — | EP | disclosed |
| EP-0365820-A1 | Utilization of optically active ester of oxygen containing heterocyclic carboxylic acids as doping agents in liquid crystalline mixtures, and those mixtures containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-05-02 | — | — | EP | disclosed |